Boesen Biotech ApS: Financial statements 2017
CVR: 39142635
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -18,750 and a net result of DKK 260,637. Equity in the 2017 report amounted to DKK 310,637. The solvency ratio was 7.7%.
- Gross Profit
- DKK -18,750
- Profit/Loss
- DKK 260,637
- Equity
- DKK 310,637
- Total Assets
- DKK 4,052,789
Official annual report
Keep an eye on Boesen Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 16, 2017, Gudter ApS is registered as an owner of Boesen Biotech ApS with an ownership share of 10%.
As of December 5, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Boesen Biotech ApS.
As of December 5, 2017, Thomas Boesen is registered as director of Boesen Biotech ApS.
Boesen Biotech ApS was founded on December 5, 2017.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.